Latest

May 12, 2017
Clinical trial data from completed trials are beginning to be shared through a variety of channels. While skeptics remain, there is evidence that this data can lead to practice-changing behavior in patient care.
May 08, 2017
The agency hopes to better use global resources and avoid duplicate inspections of foreign facilities.
May 04, 2017
Effectively addressing prior authorization challenges as part of a company’s core sales and marketing tactics can yield tangible and substantial benefits, writes Dan Rubin.
Apr 26, 2017
By Pharmaceutical Executive Editors
A new report from QuintilesIMS asks, it more advantageous to take a product to market by "Going It Alone" or by partnering with an established pharma company?
Apr 24, 2017
How companies are closing the innovation gap between the lab and the patient, while also creating value for all stakeholders.
Apr 18, 2017
Pharma must develop digital identity strategies for creating seamless, safe and compliant customer journeys, writes Jamie Beckland.
Apr 10, 2017
Nine months on from the 2016 EFPIA Disclosure Code deadline — requiring all member companies to publish data concerning their transfer-of-value transactions to HCPs — EFPIA's Andrew Powrie-Smith offered an update on media and industry responses.
Apr 10, 2017
If pharma companies want to hold their own in the current climate, they must embrace rather than resist market change, writes Peter Muller.
Apr 05, 2017
Scott Gottlieb answers Senators' questions at his confirmation hearing before the Senate Health, Education, Labor and Pensions Committee.
Apr 05, 2017
Amidst hundreds of presentations on new developments in cancer research and treatment discovery at the AACR meeting this week, FDA policies for speeding promising new therapies to patients garnered a good deal of attention.
native1_300x100
lorem ipsum